Q66R (p.Gln66Arg) variant of CXCR4 (C-X-C chemokine receptor type 4)
Q66R (p.Gln66Arg) in CXCR4 (C-X-C chemokine receptor type 4) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.49 / 1. The record also includes population frequency data and structural context.
Q66R (p.Gln66Arg) variant details
- p.Gln66Arg
- rs1428775677
- gnomAD rs1428775677
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.49
- REVEL 0.45
- MetaLR 0.32
- MetaSVM -0.39
- CADD 24.90
- PolyPhen-2 0.25
- SIFT 0.06
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Finnish in Finland (FIN) population (allele frequency 3.7e-05)
- Structural context available